Druck Icon

Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine

Berlin, 8 March 2012. The Eckert & Ziegler/EANM abstract award is entering its fifth year. Young scientists can once again participate in the competition with their innovative scientific research in the field of nuclear medicine. The submission deadline is 16 April 2012. The Travel Grant, which is awarded every year, has been established to support young scientists and doctoral students who would like to present the results of their scientific research to a wide audience - at the Annual Congress of the European Association of Nuclear Medicine (EANM) in October 2012. Five Travel Grants, in the amount of 1,000 EUR each, will be awarded by Eckert & Ziegler AG (ISIN DE0005659700), one of the leading European manufacturers of isotope products and the European Association of Nuclear Medicine (EANM). The award winners will be selected in cooperation with the EANM. The five winners will receive their awards during the EANM Annual Congress in Milan on 31 October 2012.
The goal of the Eckert & Ziegler/EANM abstract award is to strengthen the collaboration between researchers and clinicians to expedite the implementation of research findings for the benefit of the patient. We hope that this will help to ensure that the substantial progress which has been made in medical imaging can soon be transformed into more precise, faster or less expensive methods of diagnosis and therapy.

"Due to current demographic trends, we have seen a significant increase in neurodegenerative diseases, such as Alzheimer's and Parkinson's. With the Positron Emissions Tomography (PET), such diseases can be detected at an early stage and treated. Moreover, the trend of personalized medicine is being supported by nuclear medical imaging. For example, PET scans can detect the properties of a tumor, which can determine the basis for the individualized treatment of a patient," commented Dr. André Heß, Member of the Board at Eckert & Ziegler AG and Head of the Segment Radiopharma.

About Eckert & Ziegler:
The Eckert & Ziegler Group, with more than 580 employees, is one of the world's largest providers of isotope component technology for radiation therapy and nuclear medicine. Eckert & Ziegler supports the wide-spread use of PET/CT hybrid systems by expanding its production sites for radioactive contrast agents and by developing automated synthesis modules in which scientists can produce new diagnostic substances with the requisite pharmaceutical quality.

Eligibility for Participation:
All EANM members who are not older than 38 years of age at the time of submission are eligible to participate. Applications can be submitted electronically via eanm12.eanm.org. The submission deadline is 16 April 2012.

For further information, please contact:
Eckert & Ziegler AG, Karolin Riehle, Public Relations Robert-Rössle-Str. 10, D-13125 Berlin, Tel.: +49 (0) 30 / 941084-138, Fax -112
Email: karolin.riehle@dont-want-spam.ezag.de, www.ezag.de

Sitz Berlin, Amtsgericht Charlottenburg Reg.-Nr. HRB 64997 B
Vorstand: Dr. Andreas Eckert (Vorsitzender), Dr. Edgar Löffler, Dr. André Heß
Aufsichtsrat: Prof. Dr. Wolfgang Maennig (Vorsitzender)